Key result
A structured heart failure clinic model facilitates systematic GDMT titration and proactive device candidate identification.
Why the study?
Heart failure imposes a high burden of rehospitalization and mortality, requiring a structured transition from acute care to specialized longitudinal follow-up.
A structured transition from acute to outpatient care in a dedicated Heart Failure Outpatient Clinic facilitates GDMT titration and timely device therapy screening.
May warrant structured HF outpatient clinics for GDMT titration and device screening; leaves open effects on hard outcomes.
Background Heart failure (HF) represents a significant clinical and economic burden, characterized by high rates of rehospitalization and mortality. Effective management requires a structured transition from acute care to specialized longitudinal follow–up. This abstract describes the organizational model of the Heart Failure Outpatient Clinic within the Cardiology and Intensive Coronary Care Unit (UTIC) at AORN Cardarelli (Naples, Italy). Materials and Methods Patients are enrolled directly following an Emergency Department (ED) visit with a specialist cardiological consultation, or post–discharge from the Cardiology/UTIC ward. A mandatory clinical protocol is required for the first visit: patients must present a recent Transthoracic Echocardiogram (TTE) and a comprehensive panel of blood tests, including NT–proBNP levels. The clinical workflow is designed to provide intensive monitoring, with follow–up appointments scheduled at 1–month, 3–month, and 6–month intervals, tailored to the clinical severity and hemodynamic stability of the individual patient. Results The implementation of this structured model allows for the systematic titration of Guideline–Directed Medical Therapy (GDMT). By utilizing standardized entry criteria (TTE and NT–proBNP), the clinic facilitates immediate risk stratification. A key outcome of this organizational structure is the identification of candidates for non–pharmacological interventions. Patients with persistent low ejection fraction (EF ‹ 35%) are channeled into dedicated pathways for the implantation of Implantable Cardioverter Defibrillators (ICD) or Cardiac Resynchronization Therapy (CRT–D/P). This proactive approach ensures that patients receive advanced device therapy at the optimal physiological window, potentially reducing the incidence of sudden cardiac death and worsening heart failure. Conclusions The organizational model of the Heart Failure Outpatient Clinic at AORN Cardarelli demonstrates that a streamlined transition from acute to outpatient care is essential for high–quality HF management. By integrating rigorous clinical monitoring with standardized diagnostic requirements, the clinic effectively bridges the gap between hospital discharge and long–term stability. This model not only optimizes pharmacological treatment but also serves as a critical screening hub for life–saving device implantation, ultimately aiming to improve patient survival and quality of life in a high–volume tertiary care setting.
No takes yet. Share an insight, caveat, or question.
Capone et al. (2026) studied Heart failure. Structured organizational model of Heart Failure Outpatient Clinic was evaluated. A structured organizational model for a Heart Failure Outpatient Clinic facilitated systematic titration of medical therapy and proactive identification of candidates for advanced device therapy.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: